A 5 year $5.4m grant has been awarded to Profectus BioSciences and the Galveston National Laboratory (GNL) at the University of Texas Medical Branch at Galveston to support the development of a Vesicular Stomatitis virus-vectored vaccine ...
Tags: Trivalent Vaccine, rVSV-vectored filovirus, Ebola and Marburg Viruses
BD Biosciences, a segment of Becton, Dickinson and Company, has introduced new FACSJazz flow cytometer cell sorter. The FACSJazz cell sorter, including digital controls and factory-optimized settings, simplifies cellular isolation and ...
Tags: flow cytometer cell sorter, digital controls, factory-optimized settings
Fluxion Biosciences has introduced an instrument to isolate rare circulating tumor cells (CTC) which disseminate from primary tumors and circulate throughout the peripheral blood. Using the proprietary microfluidic technology, the IsoFlux ...
Tags: CTC instrument, IsoFlux System, medical device, Class I medical device
IDG News Service-The U.S.Department of Energy's Oak Ridge National Laboratory on Monday completed the deployment of a 20-petaflop supercomputer called Titan,which the lab hopes will give the U.S.an edge over China and Japan in the race to ...
Tags: U.S.supercomputing, 20-petaflop Titan, U.S.DOE, ORNL
DuPont Industrial Biosciences presented results of collaborative trials with Pacific Textiles Limited Ltd, a Hong Kong-based manufacturer of custom fabrics, which demonstrate the significant sustainability benefits of bio-based enzymes used ...
Tags: DuPont Industrial, PrimaGreen, enzymes, textile
Semprus BioSciences, a subsidiary of Teleflex, has received CE mark for its Nylus peripherally inserted central catheter (PICC) with Semprus Sustain technology from its notified body, the Netherlands-based DEKRA Certification Group. The ...
Tags: Nylus peripherally inserted central catheter, PICC, Nylus PICC
AstraZeneca, a biopharmaceutical company, has completed the purchase of a US-based biotechnology company, Ardea Biosciences. Upon completion of the merger, approved by Ardea's stockholders, each outstanding share of Ardea common stock has ...
Tags: purchase, AstraZeneca, Ardea Biosciences, biopharmaceutical
Ambit Biosciences and Teva Pharmaceutical Industries have announced the FDA clearance of CEP-32496, a novel BRAF (V600E) kinase inhibitor. The preclinical findings also demonstrate that CEP-32496 possesses potent and sustained anti-tumor ...
Tags: Ambit, Teva, FDA clearance
AstraZeneca and Ardea Biosciences have entered into a definitive merger agreement, under which AstraZeneca will acquire Ardea for $1.26bn including a product lesinurad in Phase III development for gout. As per the agreement, AstraZeneca ...
Tags: AstraZeneca, Ardea, merger agreement, gout
REGENX BioSciences has received FDA orphan drug designation for treatment of familial hypercholesterolemia (HoFH) using NAV rAAV8 vectors. The REGENX program consists of a NAV rAAV8 vector expressing a normal copy of the human ...
Tags: orphan drug designation, familial hypercholesterolemia, clinical study